Filter posts

New BIO Report on Impact of Sarbanes-Oxley 404(b) on Emerging Biotech Innovators

BIO is out with a new report illustrating the negative impact of Sarbanes-Oxley 404(b) on …

Greenwood: America Leads in Biopharmaceutical Innovation. Let’s Keep It That Way.

Writing last week for Morning Consult, BIO President and CEO Jim Greenwood proposed several policy …

You’re Invited: BIO Board Member to Discuss Challenges Facing Emerging Biotechs – and How to Fix...

Next week, MaxCyte CEO and Biotechnology Innovation Organization (BIO) Board Member Doug Doerfler will speak …

Tax Policy Should Support the Biobased Economy

BIO’s Brent Erickson today published a new column in Biofuels Digest, arguing that Congress should …